Why Pet Owners Are Rejecting Weight Loss Treatments and What They Should Do Instead As conversations around Ozempic-style weight-loss treatments for animals grow, new research from Petgevity reveals that the UK public is far from ready to embrace GLP-1 weight-loss treatments for pets. While some media outlets suggest that “Ozempic for dogs” and “fat jabs for cats” could be approved as early as 2027, British pet owners are showing concerns. These worries highlight deeper issues around pet obesity and the impact of health conditions on quality of life and pre-existing conditions. What is the GLP-1 weight-loss treatment for pets? GLP-1 (Glucagon-Like Peptide-1) is a natural hormone that helps control appetite and blood sugar. GLP-1 treatments work by prompting weight loss through slowing digestion, increasing insulin and reducing hunger. After proving highly effective in humans, similar treatments are now being explored for use in overweight pets. As trials continue, the full range of side effects is still being studied, however scientists are optimistic treatments could be approved to help manage diabetes and weight management in the not too distant future. Most Brits would never use artificial weight-loss treatments on their pets According to our study: 58% of UK pet owners say...